Emerald Health Therapeutics, Inc. Transfers US Listing to OTCQB
Vancouver, British Columbia–(Newsfile Corp. – May 6, 2022) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“Emerald” or the “Company”) announced today that it has transferred its US listing to the OTCQB after receiving notice from the OTC Markets Group that the Company no longer meets the listing requirements for continued listing on the OTCQX International tier.
On November 3, 2021, Emerald received notice that the Company’s bid price had closed below $0.10 for more than 30 consecutive calendar days and no longer met the Standards for Continued Qualification for the OTCQX International tier. The OTC Markets Group provided Emerald a cure period of 180 calendar days to have its share price close at US$0.10 or above for ten consecutive trading days. On May 4, 2022, the OTC Markets Group informed the Company that it did not meet the criteria to continue its OTCQX International Listing.
The OTC Markets Group invited Emerald to apply to list on the OTCQB, where the Company continued to meet the relevant listing requirements. The Company filed its OTCQB application to transfer its listing on May 5, 2022, and the Company will begin trading on the OTCQB at market-open today under the same symbol: EMHTF.
Please visit www.emeraldhealth.ca for more information or contact:
Mohammed Jiwan , Chief Operating Officer
1(800) 757 3536 Ext. #5
Emerald Investor Relations
(800) 757 3536 Ext. #5
invest@emeraldhealth.ca
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements: Certain statements made in this press release that are not historical facts are forward-looking statements and are subject to important risks, uncertainties and assumptions, both general and specific, which give rise to the possibility that actual results or events could differ materially from our expectations expressed in or implied by such forward-looking statements.
We cannot guarantee that any forward-looking statement will materialize, and readers are cautioned not to place undue reliance on these forward-looking statements. These statements are not historical facts but instead represent management beliefs regarding future events, many of which, by their nature are inherently uncertain and beyond management control.
The forward-looking statements contained in this press release represent our expectations as of the date hereof. Forward-looking statements are presented for the purpose of providing information about management’s current expectations and plans and allowing investors and others to obtain a better understanding of our anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes. Emerald undertakes no obligations to update or revise such statements to reflect new circumstances or unanticipated events as they occur unless required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/123022
